Last edition
News about " a fully integrated clinical site organization"
Elanco Secures USDA Approval for Befrena mAb, Strengthening Canine Dermatology Portfolio
Elanco Animal Health Incorporated has received approval from the US Department of Agriculture (USDA) for Befrena (tirnovetmab), marking the company’s entry into the fast-growing canine dermatology segment with an anti-IL-31 monoclonal antibody therapy for allergic and atopic dermatitis in dogs.
A Fully Integrated Clinical Site Organization | 03/01/2026 | By Darshana
In the past 12 months, Velocity has randomized 25,000 patients into phase II and III studies in the US. The tech investments will enable Velocity to be more efficient in managing studies, identifying patients for studies, and increasing the frequency of participation in studies
A Fully Integrated Clinical Site Organization | 16/02/2022 | By Darshana | 585
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy